| Rosacea |
0 |
0.84 |
| Isotretinoin |
0 |
1 |
| Travel Medicine |
0 |
0.38 |
| Dermatitis |
0 |
0.34 |
| West Virginia |
0 |
0.34 |
| Virginia |
0 |
0.24 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.14 |
| Hospital |
0 |
0.14 |
| Pregnancy |
0 |
0.12 |
| Patient Safety |
0 |
0.11 |
| COVID-19 |
0 |
0.1 |
| Global Warming |
0 |
0.9 |
| Outpatient Clinic |
0 |
0.1 |
| Residency |
0 |
0.1 |
| Health Care Reform |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.09 |
| Adverse Effects |
0 |
0.05 |
| Atopic Dermatitis |
0 |
0.05 |
| Burnout |
0 |
0.05 |
| Clinical Research |
0 |
0.05 |
| Endoscopy |
0 |
0.05 |
| Geriatrics |
0 |
0.05 |
| Grant |
0 |
0.05 |
| Internship |
0 |
0.05 |
| Pennsylvania |
0 |
0.05 |
| Rural Health |
0 |
0.05 |
| Teledermatology |
0 |
0.05 |
| Urban Health |
0 |
0.8 |
| Psoriasis |
0 |
0.04 |
| Skin and Soft Tissue Infection |
0 |
0.04 |